Table 1.

Patient Demographic and Clinical Characteristics

Characteristic	Patients
	No.	%
Total No. of patients enrolled	44
Eligible	42
Ineligible	2
Evaluable
Not evaluable and no treatment given	1
Evaluable for response	41
Evaluable for toxicity	41
Age, years
Median	63.5
Minimum	31.1
Maximum	84.2
Sex
Male	34	83
Female	7	17
Ethnicity
White	39	95
Black	2	5
Performance status
0	16	39
1	24	59
Primary site
Lip/oral cavity	9	22
Nasopharynx	1	2
Oropharynx	8	20
Hypopharynx	4	10
Larynx	15	37
Other/unknown	4	10
Disease status
Newly diagnosed	2	5
Persistent	3	7
Recurrent/metastatic	36	88